US EditionPET imaging gains momentum while SPECT maintains strength in nuclear medicine
Summary by Medical Device Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
PET agents gain momentum as SPECT holds strong in nuclear medicine - Express Healthcare
Though single-photon emission computed tomography (SPECT) remains the dominant modality for nuclear imaging globally, positron emission tomography (PET) imaging is gaining momentum, particularly in oncology and other high-value applications, primarily driven by tracer innovation, says GlobalData. According to GlobalData’s recently updated “Nuclear Imaging Agents” market model, the global PET imaging agent market is valued at $2.1 billion in 2025…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
